Clinical Trial Update: Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a COX-2 inhibitor for the treatment of Preeclampsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• COX-2 inhibitor (unspecified)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Preeclampsia | Phase 2 | Status: WITHDRAWN